(Q37861590)

24 August 2017

1 reference

title

Genomic profiles of glioma (English)

1 reference

24 August 2017

1

1 reference

24 August 2017

1 June 2011

1 reference

Current Neurology and Neuroscience Reports

24 August 2017

1 reference

24 August 2017

11

1 reference

24 August 2017

3

1 reference

24 August 2017

291-297

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-011-0198-7

24 August 2017

0 references

cites work

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Malignant astrocytic glioma: genetics, biology, and paths to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

A mathematical framework to determine the temporal sequence of somatic genetic events in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Gene expression profiling identifies molecular subtypes of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Gene expression profiling of gliomas strongly predicts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Discordant protein and mRNA expression in lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

IDH mutations in glioma and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Pseudoprogression and pseudoresponse in the treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

DecisionDx-GBM Gene Expression Assay for Prognostic Testing in Glioblastoma Multiform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0198-7

Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.

21 January 2018

1 reference

12 December 2020

Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.

1 reference

12 December 2020

Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling

1 reference

12 December 2020

Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis

1 reference

12 December 2020

Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

1 reference

12 December 2020

Molecular subclassification of diffuse gliomas: seeing order in the chaos

1 reference

12 December 2020

Identification of combination gene sets for glioma classification.

1 reference

12 December 2020

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma

1 reference

12 December 2020

Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets

1 reference

12 December 2020

10.1007/S11910-011-0198-7

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21465149